A T-cell test developed by Adaptive Biotechnologies could become the first commercially available test of its kind, and it may be more effective at detecting past COVID-19 infections than antibody ...
LONDON, Sept. 12, 2023 /PRNewswire/ -- Virax Biolabs Group Limited (VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced ...
SEATTLE, June 15, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ...
The Daily Galaxy on MSN
A Flaw at Last? AI Just Detected Something in Cancer Cells That Doctors Overlooked for Years
In a dedicated lab at Yale University and a data center deep inside Google DeepMind, a team of researchers may have just ...
13don MSN
Decoding the T cell burst: Signature genes predict T cell expansion in cancer immunotherapy
The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...
Discover how CAR T cell therapy is breaking new ground in treating Multiple Sclerosis for the first time in the UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback